Mylan Plans Summer Launch For Advair Generic, Now Called Wixela Inhub
Executive Summary
Wixela Inhub could be the first interchangeable generic version of the blockbuster asthma drug on the US market if it is approved by FDA.
You may also be interested in...
Mylan’s Generic Advair Delay Gives Leverage To Rivals
Mylan received a “complete response” letter from FDA on its application for a generic version of GSK’s blockbuster Advair, offering scarce details on the reason why or possible length of the delay.
Mylan’s Generic Advair Delay Gives Leverage To Rivals
Mylan received a “complete response” letter from FDA on its application for a generic version of GSK’s blockbuster Advair, offering scarce details on the reason why or possible length of the delay.
Mylan’s Generic Advair Delay Gives Leverage To Rivals
Mylan received a “complete response” letter from FDA on its application for a generic version of GSK’s blockbuster Advair, offering scarce details on the reason why or possible length of the delay.